Background: Among the complications of hydatid liver disease,frank intrabiliary rupture is a rare complication. Our therapeutic policy and various problems that we faced in dealing with this complication are discussed here. Patients and Methods: During the last 24 years, 214 patients underwent surgery for liver echinococcosis. Those 20 patients(9.3%) who had frank intrabiliary rupture of hydatid cysts were examined retrospectively. The main symptoms in these patients were jaundice and pain while the most common clinical sign was a mass in the right upper quadrant. In all patients the cysts ruptured into the biliary tree, and the cystobiliary fistula were sutured with absorbable sutures. Unroofing procedure was performed in all patients. Capitonnage was carried out in 4, omentoplasty in 4 and external tube drainage in 15 patients. All 20 patients had common bile duct exploration. Clearance of daughter cysts and cyst remnants by transduodenal sphincteroplasty was supplemented in 3 patients, by choledochoduodenostomy in 2 patients, and by Roux-en-Y cystojejunostomy in 1 patient. Results: There was no mortality. Morbidity was 15%. Complications included wound infection in 2 patients and respiratory infection in 1 patient. Mean (±SD) hospital stay was 12 ± 3 days. No recurrence of the disease was seen during a mean follow-up of 8.4 years. Conclusion: A frank intrabiliary rupture of hepatic hydatid cyst is a rare but serious event,and one should be aware of it in differential diagnosis of obstructive jaundice.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.